Dengvaxia

Sanofi's Dengvaxia gets a boost from WHO recommendation

laptop against white background

As promised, we bring you the new and improved FiercePharma

A model of a poliovirus attaching to a receptor on a cell

Worldwide switch to bivalent oral polio vaccine to kick off on Sunday

Gardasil 9 vaccine vial and box

ASCO pushes more HPV vaccine use in published recommendations

The American Society of Clinical Oncologists has released recommendations to boost the severely low rate of HPV vaccination in the United States.

Downtown Halifax, Nova Scotia, as seen from the Dartmouth waterfront

Immunovaccine pairs with security firm Leidos on Zika work

Nova Scotia's Immunovaccine and national security contractor Leidos hope their Zika vaccine approach can speed vaccine development during disease…

Pfizer Headquarters

Pfizer to 'spotlight' vaccines following Allergan bust, firm predicts

Market research firm Kalorama predicts Pfizer will continue to lean on its burgeoning vax unit in the wake of the collapse of the Allergan megamerger.

Kaketsuken headquarters, Kumamoto, Japan

Kaketsuken in talks with Astellas to sell its vaccines business

Aedes albopictus mosquito, which transmits Zika virus, Chikungunya virus, dengue fever and yellow fever

While much of the world is focused on the explosive Zika outbreak, a similar virus is spreading in in Angola with lethal consequences.

NIH

The NIH is committing millions in research funding to better understand adjuvant combinations as part of a push to promote adjuvant discovery and development.

The spread of Zika.

In a frantic effort to curb the Zika outbreak, world vaccines experts are pooling knowledge to hopefully inform vaccine development.

Genocea

When Genocea unveiled its genital herpes vaccine, it aimed to develop a therapeutic vaccine for the disease and compete with daily oral antivirals.

UC Irvine

A University of California, Irvine, team won $8 million from the DOD's Defense Threat Reduction Agency to develop a new vaccine against Q fever.

A team at the University of Texas Medical Branch has developed a mouse model to test Zika vaccines and treatments after three weeks, cutting down the usual…